← Browse by Condition
Medical Condition

weight loss

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 1, Phase 3

ClinicalMetric tracks all active clinical trials for weight loss sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — weight loss Clinical Trials

How many clinical trials are currently recruiting for weight loss?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for weight loss, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for weight loss?
weight loss research spans Phase 1 (2 trials), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a weight loss clinical trial?
Eligibility criteria for weight loss trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 3
1
Top Sponsors
University of Hohenheim 1 trial
Third Affiliated Hospital of Zhengzhou University 1 trial
Jinan University Guangzhou 1 trial
University of Alabama at Birmingham 1 trial
Chinese Academy of Sciences 1 trial

Recruiting Clinical Trials

NCT01344525
Recruiting
Pilot Project on Interdisciplinary Therapy of Obesity
Enrollment
480 pts
Location
Germany
Sponsor
University of Hohenheim
View Trial →
NCT06339840
Recruiting
The Impact of Lifestyle Intervention on Weight and Fertility in Obese Males
Enrollment
98 pts
Location
China
Sponsor
Third Affiliated Hospital of Z...
View Trial →
NCT06275061
Recruiting
Chinese Obesity and MEtabolic Surgery Database (COMES Database)
Enrollment
1,000,000 pts
Location
China
Sponsor
Jinan University Guangzhou
View Trial →
NCT06785064
Recruiting
Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
Enrollment
544 pts
Location
United States
Sponsor
University of Alabama at Birmi...
View Trial →
NCT06989203
Recruiting
Protein Supplementation Intervention on Body Weight
Enrollment
140 pts
Location
China
Sponsor
Chinese Academy of Sciences
View Trial →
NCT07540754 Phase 1
Recruiting
A Study to Evaluate the Pharmacokinetics of HRS9531 Injection in Participants With Mild, Moderate, and Normal Hepatic Function
Enrollment
24 pts
Location
China
Sponsor
Fujian Shengdi Pharmaceutical ...
View Trial →
NCT06998758 Phase 3
Recruiting
Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC
Enrollment
60 pts
Location
China
Sponsor
Sixth Affiliated Hospital, Sun...
View Trial →
NCT07223983 Phase 1
Recruiting
Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Enrollment
10 pts
Location
United States
Sponsor
Yale University
View Trial →

Related Conditions

obesity (4) male fertility (1) artificial insemination (1) ivf et (1) metabolic surgery (1) bariatric surgery (1) obesity prevention (1) weight change (1) weight loss maintenance (1) protein supplementation (1) diabetes mellitus (1) neoadjuvant chemotherapy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology